American Healthcare REIT AHR
United StatesReal Estate · REIT - Healthcare FacilitiesUSD
64.40 USD (+30.4%)
15 analysts
Trading 2120.30 €Open account ↗
Lightyear0.90 €Open account ↗
N260.90 €Open account ↗
XTB1.00 €★ featured · affiliateOpen account ↗Trading 2120.30 €Open account ↗Lightyear0.90 €Open account ↗XTB1.00 €★ featured · affiliateOpen account ↗200.00 € order · cheapest cheapest available in your country iCompare all 22 brokers →What does it do?
American Healthcare REIT, Inc. (AHR) is a real estate investment trust that owns and operates a diversified portfolio of healthcare properties, including hospitals, skilled nursing facilities, medical offices, and assisted living centers in the United States and the United Kingdom.
Key points
from its scores- ✓Strong growth8.7
- ✓Good share-price trend8.4
- ✓Very solid balance sheet7.5
- ✕Little or no dividend1.4
- ✕Little competitive advantage3.7
AI analysis
bottom line, main risk, context and newsGrowth and momentum are attractive, but valuation and dividend coverage limit near-term upside potential.
AHR shows exceptional growth (revenue +24.7%, earnings +157.5%) and solid financial health (ND/EBITDA 3.15, cash conversion 88.66%), but its valuation is demanding (EV/EBITDA 27.31) and the dividend is not covered (payout 149.25%). Momentum is strong (34.14% over 12 months), but underlying quality is weak (ROE 3.95%, ROIC 3.00%).
The 149.25% payout indicates the dividend is not covered by earnings, which could lead to a cut if growth slows or financing costs rise.
Context and risks
AHR's healthcare REIT profile carries moderate regulatory and governance exposure in the United States, with a reference risk of -0.6. The company operates in a sector with active regulatory review on Medicare/Medicaid reimbursements, which could affect the stability of its income.
Is American Healthcare REIT stock cheap or expensive?
at the analysis dateOn P/E and Price / book, it trades 161% above the Real Estate median on average.
| Multiple | Company | Sector | Difference |
|---|---|---|---|
| P/E | 73.7 | 21.6 | +241% |
| EV / EBITDA | 27.3 | 18.5 | +48% |
| Price / book | 2.6 | 1.4 | +82% |
| Price / sales | 4.3 | 6.3 | −32% |
Sector: median of the 100 Real Estate companies analysed. In bold, the multiples used for the comparison.
Valuation score: 3.7 out of 10 (median for Real Estate: 4.9).
Average analyst target: 64.40 USD, +30.4% versus the price.
A premium can be justified if the company is of higher quality or grows faster than its sector: Quality / Moat 3.7 (sector 5.2), Growth 8.7 (sector 5.7).
Classic formulas with standard assumptions (10.0% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.
Work out its fair value yourself →How much would you have made investing every month? →
Comparing it with its sector does not say whether it is a good buy: this is not investment advice.
Score by category
0 to 10 · hover overtap each one to see what it measuresKey metrics
at the analysis date · compared with the Real Estate medianValuation
- P/E
- 73.7
- Forward P/E
- 49.9
- EV / EBITDA
- 27.3
- Price / book
- 2.6
- Price / sales
- 4.3
- PEG
- 1.42
- Market cap
- 10.8B USD
- Enterprise value
- 12.2B USD
Profitability
- ROE
- 4.0%
- ROA
- 2.1%
- ROIC (approx.)
- 3.0%
- Gross margin
- 19.3%
- Operating margin
- 6.8%
- Net margin
- 4.8%
- Free cash flow
- 396.7M USD
- FCF yield
- 3.7%
- Cash conversion
- 89%
Solvency
- Total debt
- 1.6B USD
- Net debt
- 1.4B USD
- Cash
- 157.9M USD
- EBITDA
- 447.4M USD
- Net debt / EBITDA
- 3.15
- Debt / equity
- 41.89
- Current ratio
- 1.31
- Quick ratio
- 1.06
Growth
- Revenue growth
- +24.7%
- Earnings growth
- +157.5%
- EPS (TTM)
- 0.67 USD
- EPS (forward)
- 0.99 USD
Dividend
- Dividend yield
- 2.0%
- Payout
- 149.2%
Risk and market
- Beta
- 0.80
- Analyst consensus
- Strong buy (15)
- Target price
- 64.40 USD
- 52-week range
- 40.00 – 58.70
Recent news
All AHR news →Compare it with its sector
All 100 in Real Estate →Frequently asked questions about American Healthcare REIT
Is American Healthcare REIT stock cheap or expensive?
On P/E and Price / book, it trades 161% above the Real Estate median on average. Valuation score: 3.7 out of 10 (median for Real Estate: 4.9). Average analyst target: 64.40 USD, +30.4% versus the price. This is not investment advice.
What score does American Healthcare REIT get on MeridIAn Screener?
It scores 5.1 out of 10, rank 1,623 of 2,130 (better than 21% of the companies analysed). Its strongest category is Growth (8.7) and its weakest, Dividend (1.4). Analysis of 08/10/2026.
What is American Healthcare REIT's P/E ratio?
Its P/E is 73.7: the share price equals 73.7 times earnings per share over the last 12 months. The Real Estate median is 21.6. Based on the earnings analysts expect, the forward P/E is 49.9.
How much is American Healthcare REIT worth on the stock market?
Its market capitalisation is 10.8B USD.
Does American Healthcare REIT pay a dividend?
Yes: its dividend yield is 2.03% and it pays out 149% of its earnings.
How has American Healthcare REIT stock performed over the last year?
It has risen 24.2% over the last year, excluding dividends. Over the last 52 weeks it has traded between 40.00 and 58.70 USD. Past performance does not guarantee future results.
What do analysts think of American Healthcare REIT?
15 analysts cover it; their average recommendation is “Strong buy” and their average target is 64.40 USD (+30.4% versus the price). It is an estimate, not market data.